-+ 0.00%
-+ 0.00%
-+ 0.00%

JW Pharmaceutical Q3 Operating Profit Falls 10.7% Year on Year

PUBT·11/04/2026 08:01:47
Listen to the news
JW Pharmaceutical Q3 Operating Profit Falls 10.7% Year on Year
  • JW Pharmaceutical’s third-quarter 2026 net profit fell 35.5% year over year to KRW 19.84 billion.
  • Operating profit declined 10.7% year over year to KRW 29.15 billion.
  • Revenue rose 6.3% from a year earlier to KRW 211.12 billion.
  • For the first nine months of 2026, net profit increased 62.9% to KRW 75.36 billion.
  • Nine-month revenue grew 10.2% to KRW 629.86 billion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JW Pharmaceutical Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261104800468), on November 04, 2026, and is solely responsible for the information contained therein.